Company / Capital Expenditures
DNA X, Inc. Capital Expenditures History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$36.0K
FY2024
5-year range
$8.0K / $992.0K
FY2020-FY2024
Trend
+350.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures changed +350% YoY in FY2024, a notable deviation from the 5-year average annual change of +103%.
Based on SEC 10-K filings.
$36,000 in FY2024 with a 5-year CAGR of -46.0%.
Declined from $46,000 to $36,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +48.5%
- 5-Year CAGR
- -46.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -46.0%, indicating a declining trend.
- In FY2024, capital expenditures increased 350.0% year-over-year.
- Peak capital expenditures was recorded in FY2020.
- Lowest capital expenditures in the period was in FY2023.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $36.0K | +350.0% |
| FY2023 | $8.0K | -82.6% |
| FY2022 | $46.0K | +318.2% |
| FY2021 | $11.0K | -98.9% |
| FY2020 | $992.0K | +26.0% |
| FY2019 | $787.0K | - |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026